mdlinx mdlinx
Latest (257) Full Text Articles (9654) Focus on Substance Abuse Article Summary

Trans-epithelial transport of the betalain pigments indicaxanthin and betanin across Caco-2 cell monolayers and influence of food matrix
European Journal of Nutrition, 08/08/2012

Tesoriere L et al. – Dietary indicaxanthin and betanin can substantially be absorbed through paracellular junctions of intestinal epithelial cells. Additional trans–membrane permeation can be considered for betanin, whose absorption is limited by a MRP2–mediated efflux and negatively affected by its food matrix. Present findings are consistent with the quite higher bioavailability of indicaxanthin over betanin established in humans.

Methods
  • Trans–epithelial transport of dietary–consistent amounts of indicaxanthin and betanin in Caco–2 cell monolayers seeded on TranswellR inserts was measured in apical to basolateral (AP–BL) and basolateral to apical (BL–AP) direction, under an inwardly directed pH gradient (pH 6.0/7.4, AP/BL) mimicking luminal and serosal sides of human intestinal epithelium.
  • The effect of inhibitors of membrane transporters on the absorption was also evaluated.
  • Contribution of the paracellular route was investigated after EDTA treatment of the cell monolayer.
  • In vitro digestion of betalainic food was performed to provide a post–intestinal fraction containing bioaccessible pigments.

Results
  • Apparent permeability coefficients (P app) in the absorptive direction were (4.4 ± 0.4) × 10–6 and (3.2 ± 0.3) × 10–6 cm s–1 for indicaxanthin and betanin, respectively.
  • Transport of indicaxanthin was non–polarized, linear as a function of time and concentration, and unaffected by inhibitors of membrane transporters.
  • Betanin exhibited significantly different bidirectional P app values and non–linear efflux kinetics.
  • The concentration–dependent betanin efflux was described by a kinetic model including one non–saturable (K d=0.042 μL cm–2 min–1) and one saturable component identified as the apical multidrug resistance–associated protein 2 (MRP2; K m =275 μM; J max=42 pmol min–1 cm–2).
  • Permeation of both betalains increased remarkably after EDTA treatment of the cell monolayer.
  • Neither indicaxanthin nor betanin underwent metabolic transformation.
  • Food matrix did not affect trans–epithelial transfer of indicaxanthin, but reduced the absorption rate of betanin, red beet more than cactus pear.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Last month's top read Top Articles of 2012

1 Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction Arteriosclerosis, Thrombosis, and Vascular Biology, April 17, 2013    Clinical Article

2 Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Full Text New England Journal of Medicine, April 8, 2013    Continuing Medical Education    Free full text

3 Vitamin D Levels for Preventing Acute Coronary Syndrome and Mortality: Evidence of a Non-Linear Association Journal of Clinical Endocrinology and Metabolism, March 27, 2013    Clinical Article
Exclusive Author Commentary

4 Advances in Stroke Prevention in Atrial Fibrillation: Enhanced Risk Stratification Combined With the Newer Oral Anticoagulants Full Text Clinical Cardiology, April 11, 2013    Free full text    Review Article    Clinical Article

5 Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials British Medical Journal, April 25, 2013    Evidence Based Medicine    Review Article

6 The Risk of Taking Ascorbic Acid JAMA Internal Medicine, February 5, 2013    Clinical Article

7 Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial The Lancet, April 18, 2013    Clinical Article

8 Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial Diabetes Care, April 9, 2013    Clinical Article

9 Enalapril And Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients with Malignant Hemopathies. The OVERCOME Trial JACC - Journal of the American College of Cardiology, April 12, 2013    Clinical Article

10 Drug Interactions with Grapefruit Juice Full Text British Journal of Medical Practitioners, February 12, 2013    Free full text    Clinical Article

11 Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial European Heart Journal, April 22, 2013    Clinical Article

12 Pulmonary hypertension: diagnosis and management British Medical Journal, April 23, 2013    Continuing Medical Education    Review Article

13 Infective Endocarditis New England Journal of Medicine, April 12, 2013    Clinical Article

14 Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels -- Results from a randomized trial European Journal of Internal Medicine , April 11, 2013    Clinical Article

15 Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement Annals of Internal Medicine, February 26, 2013    Clinical Guideline

16 Infective Endocarditis New England Journal of Medicine, April 24, 2013    Continuing Medical Education    Review Article

17 Osteoporosis treatment European Journal of Internal Medicine , April 24, 2013    Clinical Article

18 Bone mineral density testing: Is a T score enough to determine the screening interval? Full Text Cleveland Clinic Journal of Medicine, April 3, 2013    Continuing Medical Education    Free full text

19 The impact of coffee on health Maturitas, February 26, 2013    Clinical Article

20 Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials Full Text Cardiovascular Diabetology, April 12, 2013    Free full text    Clinical Article

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Other Topics in Internal Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close